photodynamic therapy

Type: Keyphrase
Name: photodynamic therapy
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Now, photodynamic therapy to kill deep-set cancer cells

12:02 am Washington : A new research has revealed about an FDA-approved photodynamic therapy that on being combined with a new type of nanoparticle effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side ... [Published The Freepress Journal - Oct 17 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Discovery may lead to lower doses of chemotherapy

No matter what type of chemotherapy you attack a tumor with, many cancer cells resort to the same survival tactic: They start eating themselves.Scientists at Brigham Young University discovered the two proteins that pair up and switch on this process ... [Published Health Canal - Oct 16 2014]
Entities: Chemotherapy, Protein, Tumor
First reported Oct 15 2014 - Updated Oct 16 2014 - 4 reports

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with min ... [Published BioPortfolio - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Studies from CHA University Describe New Findings in Clinical Trials and Studies (Fertility preservation by photodynamic therapy combined with...

Studies from CHA University Describe New Findings in Clinical Trials and Studies (Fertility preservation by photodynamic therapy combined with conization in young patients with early stage cervical cancer: A pilot study)By a News Reporter-Staff News Editor ... [Published 4 Traders - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

NCI’s Center for Global Health Announces First Major Research Grants to Support Portable Technologies

Jonathan Celli, PhDTayyaba Hasan, PhDKathleen Schmeler, MDRebecca Richards-Kortum, PhDMiriam Cremer, MDLouise Kuhn, PhDRobert Murphy, MDJean Anderson, MDAct with LoveThe National Cancer Institute (NCI) Center for Global Health announced grants that will ... [Published The ASCO Post - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

In vitro combination therapy using low dose clotrimazole and photodynamic therapy leads to enhanced ...

Superficial infections of the skin and mucous membranes caused by dermatophyte fungi are amongst the most common and challenging infections to treat. Previously we demonstrated the phototoxic effects of photodynamic therapy (PDT) towards Trichophyton ... [Published 7thSpace - Oct 15 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

Research and Markets: Future Oncology: Technology, Products, Market and Service Opportunities

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( http://www.researchandmarkets.com/research/9n7f6t/future_oncology ) has announced the addition of the "Future Oncology: Technology, Products, Market and Service Opportunities" subscription to their off ... [Published CNBC - Oct 14 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 2 reports

Pinnacle begins Phase III bile duct cancer trial of PHOTOFRIN

Concordia Healthcare subsidiary Pinnacle Biologics has started an open-label, multicenter Phase III trial (OPUS) designed to evaluate the efficacy and safety of Photodynamic therapy (PDT) with PHOTOFRIN (porfimer sodium) for injection to treat cholan ... [Published BioPortfolio - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 2 reports

Pinnacle begins Phase III bile duct cancer trial of PHOTOFRIN

Concordia Healthcare subsidiary Pinnacle Biologics has started an open-label, multicenter Phase III trial (OPUS) designed to evaluate the efficacy and safety of Photodynamic therapy (PDT) with PHOTOFRIN (porfimer sodium) for injection to treat cholangiocarcinoma ... [Published PBR - News - Oct 08 2014]
First reported Oct 02 2014 - Updated Oct 03 2014 - 5 reports

Quest PharmaTech, Bioceltran ink licence deal for photodynamic therapy technology

Quest PharmaTech has agreed to license its photodynamic therapy (PDT) technology to South Korea-based firm Bioceltran in return for up-front license fees, milestone payments and royalties on future product sales. ... [Published PBR - News - Oct 03 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

Reversing Sun Damage: The Latest Non-Surgical Treatment Options

, Women’s Health Magazine offered its online readers a primer on sun screen use and treatments options for sun damaged skin. Dr. Simon Ourian of Epione Medical Corporation comments on the article and offers his suggestions for repairing sun damage with ... [Published PRWeb - Sep 30 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 2 reports

Quantel Medical photodynamic therapy laser garners CE Mark approval

Quantel Medical (Clermont-Ferrand, France) has received CE Mark approval for its Vitra PDT photodynamic therapy laser platform in treating the ophthalmic conditions polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). The company ... [Published OptoIQ - Sep 23 2014]

Quotes

..."Dr. Arkady Mandel, Chief Scientific Officer of Theralase Inc. stated that, "Our dedicated team of scientists have worked tirelessly to prove the safety and efficacy of the Theralase PDC platform in the destruction of cancer and bacteria. I am delighted that their hard work is receiving the international accreditation that it deserves."
Original Article: NEXT ARTICLE More From BioPortfolio on "Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells"
...According to news reporting originating in Gyeonggi Do, South Korea , by NewsRx journalists, research stated, "Vaginal radical trachelectomy (VRT) is the standard fertility preserving procedure for early stage cervical cancer patients. There have been reports in the literature, however, that VRT to be too radical procedure for early stage cervical cancer, as its post-operative obstetric morbidity was high."
"This approach is an exciting new development for cancer treatment that is both effective and nontoxic" Han said in a statement

More Content

All (135) | News (121) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (1) | Press Releases (1)
sort by: Date | Relevance
'Must-attend' Photonics Asia highlighted resear... [Published Digital Journal - 14 hours ago]
Now, photodynamic therapy to kill deep-set canc... [Published The Freepress Journal - Oct 17 2014]
Exploring the Anti-Cancer Activity of Novel Thi... [Published Plosone.org - Oct 16 2014]
Cryptic clues drive new theory of bowel cancer ... [Published Health Canal - Oct 16 2014]
Researchers create DNA-based ‘nano-cocoons’ to ... [Published Health Canal - Oct 16 2014]
Discovery may lead to lower doses of chemotherapy [Published Health Canal - Oct 16 2014]
Theralase shows PDCs are stable in human urine [Published Stockwatch - Oct 16 2014]
( TLTFF TLT.V ) Theralase Presents Latest Resea... [Published Scottrade - Oct 16 2014]
Scientists combine new type of nanoparticle wit... [Published BioPortfolio - Oct 16 2014]
Now, 'photodynamic therapy' to kill deep-set ca... [Published Sify - Oct 16 2014]
Studies from CHA University Describe New Findin... [Published 4 Traders - Oct 16 2014]
UMass researchers expand use of light to treat ... [Published WBJournal.com - Oct 15 2014]
Sanovas awarded seminal patent for radiation on... [Published Medical Devices Business Review - Oct 15 2014]
NCI’s Center for Global Health Announces First ... [Published The ASCO Post - Oct 15 2014]
Nanoparticle-based photodynamic therapy to effe... [Published Nanowerk - Oct 15 2014]
In vitro combination therapy using low dose clo... [Published 7thSpace - Oct 15 2014]
Research and Markets: Future Oncology: Technolo... [Published CNBC - Oct 14 2014]
Renowned Dermatologist Dr. Sabrina Fabi Partici... [Published Digital Journal - Oct 10 2014]
CCMB director selected for Ramineni Foundation,... [Published Times of India - Oct 10 2014]
Targeted nanoparticles: Imaging, treatment comb... [Published Science Daily - Oct 09 2014]
New Theranostic Nanoparticle Diagnoses and Trea... [Published Spectrum Online - Oct 09 2014]
New Theranostic Nanoparticle Diagnoses and Trea... [Published IEEE Spectrum - Oct 09 2014]
Targeting Breast Cancer Tumors with Light [Published Noodls - Oct 09 2014]
Energy metabolism targeted drugs synergize with... [Published RSC - Oct 09 2014]
ASU engineer earns NSF award for imaging techno... [Published Arizona State University - Oct 09 2014]
Patent Issued for Water-Soluble Porphyrin and P... [Published 4 Traders - Oct 08 2014]
Pinnacle begins Phase III bile duct cancer tria... [Published BioPortfolio - Oct 08 2014]
Phase 3 trial now recruiting for treatment of r... [Published Orthopedics Today - Oct 08 2014]
Pinnacle begins Phase III bile duct cancer tria... [Published PBR - News - Oct 08 2014]
Targeted nanoparticles that combine imaging wit... [Published PhysOrg.com - Oct 08 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
New Theranostic Nanoparticle Diagnoses and Trea... [Published IEEE Spectrum - Oct 09 2014]
<?xml version="1.0" encoding="UTF-8"?> Image: Anne Weston/Getty Images So-called “theranostic” nanoparticles are capable of providing both a diagnostic as well as a therapeutic function in the same nanoparticle. Such theranostic nanoparticles ...
Pinnacle begins Phase III bile duct cancer tria... [Published PBR - News - Oct 08 2014]
Concordia Healthcare subsidiary Pinnacle Biologics has started an open-label, multicenter Phase III trial (OPUS) designed to evaluate the efficacy and safety of Photodynamic therapy (PDT) with PHOTOFRIN (porfimer sodium) for injection to treat cholangiocarcinoma ...
Pinnacle Biologics, Inc., a subsidiary of Conco... [Published PR Newswire: Health - Oct 07 2014]
University of Mannheim Medical Center is first site openedTORONTO and CHICAGO, Oct. 7, 2014 /PRNewswire/ - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia") (TSX: CXR) (OTCQX: CHEHF), announced today the ...
Quest PharmaTech, Bioceltran ink licence deal f... [Published PBR - News - Oct 03 2014]
Quest PharmaTech has agreed to license its photodynamic therapy (PDT) technology to South Korea-based firm Bioceltran in return for up-front license fees, milestone payments and royalties on future product sales. ...
Quest PharmaTech Signs License Agreement With B... [Published Marketwire - Breaking News Releases - Oct 02 2014]
EDMONTON, ALBERTA--(Marketwired - Oct. 2, 2014) - Quest PharmaTech Inc. (TSX VENTURE:QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that it has signed a license ...
1 2 3

Press Releases

sort by: Date | Relevance
The Odette Cancer Centre at Sunnybrook Health S... [Published Financial Services - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.